Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19 Therapeutic

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock